The government has approved the sale of Indian Medicines Pharmaceutical Corporation Ltd. Skymap Pharmaceuticals Pvt Ltd will acquire the company for over Rs 121 crore. This strategic sale involves 100 percent stake and management control. IMPCL manufactures A… For the full story, visit the source.
BusinessDelhi
Government okays Skymap Pharmaceuticals' Rs 121-cr bid to buy IMPCL
The government has approved the sale of Indian Medicines Pharmaceutical Corporation Ltd. Skymap Pharmaceuticals Pvt Ltd will acquire the company for over Rs 121 crore. This strategic sale involves 100 percent stake and management control. IMPCL manufactures A…
By PTI· The Times of India· 2 days ago· 2 min read
This summary is sourced from The Times of India. Read the full article at:The Times of India